RxDoctor Payments Data

Joshua Robins, MD

Vascular Surgery · Greensboro, NCNPI 1275064644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 44.5% of the total. Reporting peaked in 2022 at $750 and has fallen 52.7% since, to $355 in 2025. That places this record below the midpoint for vascular surgery clinicians in NC, where the typical reported total is $2,786.

$2,345in general payments, 2019–2025

Across 43 payments — averaging $54.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$1K
  • Boston Scientific$381
  • Stryker$196
  • Penumbra, Inc.$153
  • Silk Road Medical, Inc.$148
  • Angiodynamics, Inc.$134
  • plus $288 from 8 others

What the payments were for

  • Travel & lodging$181%
  • Food & beverage$2,21394%
  • Education$1145%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,345 in reported general payments places this provider in the 45th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024
$83,677
Medicare patients
464
Services billed
845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban16$13,554
ClopidogrelClopidogrel Bisulfate204$1,914
Cilostazol23$387
Atorvastatin Calcium17$328
Rosuvastatin Calcium19$99

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Greensboro

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →